Exatecan

Unknown Manufacturer

Exatecan has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Lung Cancer, and Liver Cancer, among others.

Generate AI report

Overview

Exatecan has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Lung Cancer, and Liver Cancer, among others.

Technical identifiers

Chemical Formula: C₂₄H₂₂FN₃O₄
CAS Number: 171335-80-1
UNII ID: OC71PP0F89

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES THEREOF
EP 4211145 B1Applicant: GENEQUANTUM HEALTHCARE SUZHOU CO LTDPriority: 2021
CN
EP
US
WO
11 publications
ANTI-MUC1- EXATECAN ANTIBODY-DRUG CONJUGATE
EP 4249002 A2Applicant: DAIICHI SANKYO CO LTDPriority: 2018
CN
EP
US
WO
7 publications
LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
EP 3858386 A4Applicant: JIANGSU HENGRUI MEDICINE COPriority: 2018
CN
EP
US
WO
7 publications
ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD
- EP 4534101 A1
  Applicant: LILLY CO ELIPriority: 2023
  EP
  US
  WO
  6 publications
- EP 4534102 A1
  Applicant: LILLY CO ELIPriority: 2023
  EP
ANTI-B7H3 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICINAL USE THEREOF
EP 3854816 A4Applicant: JIANGSU HENGRUI MEDICINE COPriority: 2018
CN
EP
US
WO
5 publications
ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF
US 2023055408 A1Applicant: JIANGSU HENGRUI MEDICINE COPriority: 2019
CN
EP
US
WO
5 publications
ANTI-CD79B ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
EP 4190812 A1Applicant: TUOJIE BIOTECH SHANGHAI CO LTDPriority: 2020
EP
US
WO
5 publications
ANTI-CEACAM5 ANTIBODY DRUG CONJUGATES
EP 4658320 A1Applicant: BRISTOL MYERS SQUIBB COPriority: 2024
EP
US
WO
5 publications
ANTI-TROP-2 ANTIDODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF
EP 4095148 A4Applicant: JIANGSU HENGRUI MEDICINE COPriority: 2020
CN
EP
US
WO
4 publications
ANTI-PSMA ANTIBODY-EXATECAN ANALOGUE CONJUGATE AND MEDICAL USE THEREOF
EP 4130006 A4Applicant: JIANGSU HENGRUI PHARMACEUTICALS CO LTDPriority: 2020
CN
EP
US
WO
4 publications

Drugs

Exatecan

Overview

Patents

ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD